Enhanced systemic exposure of saquinavir via the concomitant use of curcumin-loaded solid dispersion in rats

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 5, 2013, Pages 800-804

  Kim, Su A ^a   Kim, Sung Whan ^a   Choi, Hoo Kyun ^b   Han, Hyo Kyung ^a  

^a Dongguk University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Bioavailability; Curcumin; P gp; Saquinavir; Solid dispersion

Indexed keywords

CURCUMIN; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE 123; SAQUINAVIR; SOLUTOL HS 15;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL LINE; CELL TRANSPORT; CONTROLLED STUDY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXPOSURE; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; RAT; SOLID DISPERSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84885041360     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.05.029     Document Type: Article

References (31)

1. Aggarwal, B.B., Sundaram, C., Malani, N., Ichikawa, H., 2007. Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595, 1-75.
2. Appiah-Opong, R., de Esch, I., Commandeur, J.N., Andarini, M., Vermeulen, N.P., 2008. Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues. Eur. J. Med. Chem. 43, 1621-1631.
3. Bittner, B., González, R.C., Walter, I., Kapps, M., Huwyler, J., 2003. Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats. Biopharm. Drug Dispos. 24, 173-181. (Pubitemid 36656391)
4. Conteas, C.N., Panossian, A.M., Tran, T.T., Singh, H.M., 2009. Treatment of HIVassociated diarrhea with curcumin. Dig. Dis. Sci. 54, 2188-2191.
5. Coon, J.S., Knudson, W., Clodfelter, K., Lu, B., Weinstein, R.S., 1991. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res. 51, 897-902.
6. Dodiya, S.S., Chavhan, S.S., Sawant, K.K., Korde, A.G., 2011. Solid lipid nanoparticles and nanosuspension formulation of saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies. J. Microencapsul. 28, 515-527.
7. Gandapu, U., Chaitanya, R.K., Kishore, G., Reddy, R.C., Kondapi, A.K., 2011. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. PLoS One 6, e23388.
8. Goel, A., Kunnumakkara, A.B., Aggarwal, B.B., 2008. Curcumin as "Curecumin": from kitchen to clinic. Biochem. Pharmacol. 75, 787-809.
9. Gupta, S.C., Patchva, S., Koh, W., Aggarwal, B.B., 2012. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol. 39, 283-299.
10. Gursoy, R.N., Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58, 173-182. (Pubitemid 38479922)
11. Han, H.K., Lee, B.J., Lee, H.K., 2011. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation. Int. J. Pharm. 415, 89-94.
12. Hirunpanich, V., Sato, H., 2006. Docosahexaenoic acid (DHA) inhibits saquinavir metabolism in-vitro and enhances its bioavailability in rats. J. Pharm. Pharmacol. 58, 651-658.
13. Hsu, A., Granneman, G.R., Cao, G., Carothers, L., el-Shourbagy, T., Baroldi, P., Erdman, K., Brown, F., Sun, E., Leonard, J.M., 1998. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin. Pharmacol. Ther. 63, 453-464. (Pubitemid 28214969)
14. Kimura, Y., Ito, H., Ohnishi, R., Hatano, T., 2010. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem. Toxicol. 48, 429-435.
15. Kitchen, V.S., Skinner, C., Ariyoshi, K., Lane, E.A., Duncan, I.B., Burckhardt, J., Burger, H.U., Bragman, K., Pinching, A.J., Weber, J.N., 1995. Safety and activity of saquinavir in HIV infection. Lancet 345, 952-955.
16. Kupferschmidt, H.H., Fattinger, K.E., Ha, H.R., Follath, F., Krähenbühl, S., 1998. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br. J. Clin. Pharmacol. 45, 355-359. (Pubitemid 28138827)
17. Kuttan, R., Bhanumathy, P., Nirmala, K., George, M.C., 1985. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 29, 197-202. (Pubitemid 16175818)
18. Limtrakul, P., Anuchapreeda, S., Buddhasukh, D., 2004. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4, 13.
19. Luo, S., Wang, Z., Patel, M., Khurana, V., Zhu, X., Pal, D., Mitra, A.K., 2011. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir. Int. J. Pharm. 414, 77-85.
20. Mouly, S.J., Paine, M.F., Watkins, P.B., 2004. Contributions of CYP3A4, Pglycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir. J. Pharmacol. Exp. Ther. 308, 941-948. (Pubitemid 38263969)
21. Noble, S., Faulds, D., 1996. Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection. Drugs 52, 93-112.
22. Pathak, S.M., Musmade, P., Dengle, S., Karthik, A., Bhat, K., Udupa, N., 2010. Enhanced oral absorption of saquinavir with methyl-beta- cyclodextrinpreparation and in vitro and in vivo evaluation. Eur. J. Pharm. Sci. 41, 440-451.
23. Qiang, F., Lee, B.J., Ha, I., Kang, K.W., Woo, E.R., Han, H.K., 2010. Effect of maceligan on the systemic exposure of paclitaxel: in vitro and in vivo evaluation. Eur. J. Pharm. Sci. 41, 226-231.
24. Reddy, R.C., Vatsala, P.G., Keshamouni, V.G., Padmanaban, G., Rangarajan, P.N., 2005. Curcumin for malaria therapy. Biochem. Biophys. Res. Commun. 326, 472-474. (Pubitemid 39593570)
25. Seo, S.W., Han, H.K., Chun, M.K., Choi, H.K., 2012. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier. Int. J. Pharm. 424, 18-25.
26. Sinko, P.J., Kunta, J.R., Usansky, H.H., Perry, B.A., 2004. Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits. J. Pharmacol. Exp. Ther. 310, 359-366. (Pubitemid 38812731)
27. Srimal, R.C., Dhawan, B.N., 1973. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25, 447-452.
28. Tønnesen, H.H., Karlsen, J., 1985. Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z. Lebensm.-Unters. Forsch. 180, 402-404.
29. Usansky, H.H., Hu, P., Sinko, P.J., 2008. Differential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley rats. Drug Metab. Dispos. 36, 863-869. (Pubitemid 351574883)
30. Xu, D., Lu, Q., Hu, X., 2006. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett. 243, 274-280. (Pubitemid 44485849)
31. Yue, G.G., Cheng, S.W., Yu, H., Xu, Z.S., Lee, J.K., Hon, P.M., Lee, M.Y., Kennelly, E.J., Deng, G., Yeung, S.K., Cassileth, B.R., Fung, K.P., Leung, P.C., Lau, C.B., 2012. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J. Med. Food 15, 242-252.